
GLP-1 Users and Doctors Reject Trump's 'Fat Drug' Label as Stigmatizing
President Donald Trump’s repeated use of the terms 'fat shots' and 'fat drugs' to describe GLP-1 medications has drawn sharp criticism from medical professionals and patients. While the administration has worked to lower drug prices, critics argue the language stigmatizes obesity and ignores the medications' broad therapeutic benefits. Users report that these drugs are life-changing for conditions beyond weight loss, including diabetes and heart disease, and urge policymakers to focus on expanding Medicaid coverage rather than using derogatory terminology.













